A031702: A Phase II Study of Ipilimumab, Cabozantinib, & Nivolumab in Rare Genitourinary Cancers (ICONIC)
Genitourinary Cancer, Bladder Cancer, Renal Cancer Clinical Trial
The purpose of this study is to test the good and bad effects of the drugs called cabozantinib, nivolumab and ipilimumab, when given in combination.
Disease/Condition: Genitourinary Cancer, Bladder Cancer, Renal Cancer
Department: Hematology & Oncology
Location(s): Lahey Clinic (Burlington)
Protocol #: 20193097
Principal Investigator(s): Brendan J. Connell
